Issue |
BIO Web Conf.
Volume 52, 2022
International Scientific-Practical Conference “Agriculture and Food Security: Technology, Innovation, Markets, Human Resources” (FIES 2022)
|
|
---|---|---|
Article Number | 00039 | |
Number of page(s) | 5 | |
DOI | https://doi.org/10.1051/bioconf/20225200039 | |
Published online | 21 September 2022 |
Effect of colistin sulfate in the health status and bacteriological gut flora in store pigs with nonspecific gastroenteritis
1 K.I. Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology (MVA) FSBEI HE, Moscow, Russia
2 Samara State Agrarian University FSBEI HE, 2 Uchebnaya St., Kinelsky urban locality, Samara region, Russia
3 Samara State Medical University FSBEI HE, Ministry of Health of the Russian Federation, Samara, Russia
Piglets with the nonspecific gastroenteritis received Colistin 12000000 with drinking water for 5 days is the doses 0.6 g/100 kg in Group 1 and 0.8 g/100 kg in Group 2. This provided the complete therapeutic efficacy (the clinical recovery) on Day 4 in both treatment groups. The dynamics of the erythrocytes and leukocytes suggested the recovery of the morphofunctional homeostasis after the disease in both treatment groups. After the treatment with the Colistin 12000000, the prevalence of the Streptococcus gallolyticus reduced by 8.3% in the Group 1. Klebsiella pneumoniae prevalence reduced by 33.3%. In Group 2, the prevalence of Streptococcus gallolyticus reduced by 41.7% after the 5-day therapy and was 25.0% at the end of the study. Klebsiella pneumoniae prevalence reduced twice, and it was ultimately observed in 16.7% of cases. Other bacteria presented in the washings at the baseline in both groups were no more observed at the end of the treatment. The symbiotic flora was found in both groups at the end of the experiment in a sufficient number. Thus, the efficient dose of the test drug was 0.6 g/100 kg provided the desirable clinical effect comparable to the higher dosing regimen. The drug well tolerated, with no side effects or adverse events reported throughout the study.
© The Authors, published by EDP Sciences
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.